Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Milsom

Showing results (161-170 of 169) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 169 results.
International Journal of Clinical Practice|April 8, 2014
Safety and tolerability of the β3 -adrenoceptor agonist mirabegron, for the treatment of overactive bladder: results of a prospective pooled analysis of three 12-week randomised Phase III trials and of a 1-year randomised Phase III trialV W Nitti, C R Chapple, C Walters, et al.
International Journal of Clinical Practice|December 31, 2013
Urgency and pain in patients with overactive bladder and bladder pain syndrome. What are the differences?D Castro-Diaz, L Cardozo, C R Chapple, et al.
Human Reproduction (Oxford, England)|June 10, 2006
Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 microg ethinyl estradiol and 3 mg drospirenoneI Milsom, I Lete, A Bjertnaes, et al.
Maturitas|July 14, 2001
Knowledge, attitudes and management strategies in Scandinavia concerning hormone replacement therapy: a comparison between gynecologists in Denmark, Norway and SwedenS T Nilsen, A T Pedersen, M H Moen, et al.
International Journal of Clinical Practice|December 16, 2014
Is there a link between overactive bladder and the metabolic syndrome in women? A systematic review of observational studiesF Bunn, M Kirby, E Pinkney, et al.
International Journal of Clinical Practice|September 20, 2006
Overactive bladder: The importance of new guidanceM Kirby, W Artibani, L Cardozo, et al.
International Journal of Clinical Practice|September 30, 2008
Overactive Bladder and Continence Guidelines: implementation, inaction or frustration?A Wagg, L Cardozo, C Chapple, et al.
Neurourology and Urodynamics|December 22, 2009
Pelvic organ prolapse and overactive bladderT A de Boer, S Salvatore, L Cardozo, et al.
Neurourology and Urodynamics|December 22, 2009
Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinenceP Abrams, K E Andersson, L Birder, et al.
Pageof 17

Showing results (161-170 of 169) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 169 results.
International Journal of Clinical Practice|April 8, 2014
Safety and tolerability of the β3 -adrenoceptor agonist mirabegron, for the treatment of overactive bladder: results of a prospective pooled analysis of three 12-week randomised Phase III trials and of a 1-year randomised Phase III trialV W Nitti, C R Chapple, C Walters, et al.
International Journal of Clinical Practice|December 31, 2013
Urgency and pain in patients with overactive bladder and bladder pain syndrome. What are the differences?D Castro-Diaz, L Cardozo, C R Chapple, et al.
Human Reproduction (Oxford, England)|June 10, 2006
Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 microg ethinyl estradiol and 3 mg drospirenoneI Milsom, I Lete, A Bjertnaes, et al.
Maturitas|July 14, 2001
Knowledge, attitudes and management strategies in Scandinavia concerning hormone replacement therapy: a comparison between gynecologists in Denmark, Norway and SwedenS T Nilsen, A T Pedersen, M H Moen, et al.
International Journal of Clinical Practice|December 16, 2014
Is there a link between overactive bladder and the metabolic syndrome in women? A systematic review of observational studiesF Bunn, M Kirby, E Pinkney, et al.
International Journal of Clinical Practice|September 20, 2006
Overactive bladder: The importance of new guidanceM Kirby, W Artibani, L Cardozo, et al.
International Journal of Clinical Practice|September 30, 2008
Overactive Bladder and Continence Guidelines: implementation, inaction or frustration?A Wagg, L Cardozo, C Chapple, et al.
Neurourology and Urodynamics|December 22, 2009
Pelvic organ prolapse and overactive bladderT A de Boer, S Salvatore, L Cardozo, et al.
Neurourology and Urodynamics|December 22, 2009
Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinenceP Abrams, K E Andersson, L Birder, et al.
Pageof 17